SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-240392
Filing Date
2018-08-07
Accepted
2018-08-07 07:48:34
Documents
3
Period of Report
2018-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d577233d8k.htm 8-K 16916
2 EX-99.1 d577233dex991.htm EX-99.1 75568
3 GRAPHIC g577233g0807073710952.jpg GRAPHIC 2998
  Complete submission text file 0001193125-18-240392.txt   98007
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 18996314
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1